Live feed
Filing
SC 13D
SC 13D0001193125-21-111505·Design Therapeutics, Inc.
Schedule 13D ownership disclosure
Design Therapeutics Inc
Security class unavailable · CUSIP: 25056L103
Event date: 2021-03-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-111505
- Form type
- SC 13D
- Filer
- Design Therapeutics, Inc.
- CIK
- CIK 1807120
- Filed
- Apr 09, 2021
- Reporting period
- Mar 30, 2021
- Description
- Schedule 13D beneficial ownership